271 related articles for article (PubMed ID: 22086774)
1. [Stem cell-induced liver regeneration].
Knoefel WT; Alexander A; Tustas RY; Schmelzle M; Klein HM; Krieg A; Topp SA; Eisenberger CF; Fuerst G; Schulte am Esch J
Zentralbl Chir; 2013 Apr; 138(2):166-72. PubMed ID: 22086774
[TBL] [Abstract][Full Text] [Related]
2. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.
Fürst G; Schulte am Esch J; Poll LW; Hosch SB; Fritz LB; Klein M; Godehardt E; Krieg A; Wecker B; Stoldt V; Stockschläder M; Eisenberger CF; Mödder U; Knoefel WT
Radiology; 2007 Apr; 243(1):171-9. PubMed ID: 17312278
[TBL] [Abstract][Full Text] [Related]
3. Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.
am Esch JS; Schmelzle M; Fürst G; Robson SC; Krieg A; Duhme C; Tustas RY; Alexander A; Klein HM; Topp SA; Bode JG; Häussinger D; Eisenberger CF; Knoefel WT
Ann Surg; 2012 Jan; 255(1):79-85. PubMed ID: 22156926
[TBL] [Abstract][Full Text] [Related]
4. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.
am Esch JS; Knoefel WT; Klein M; Ghodsizad A; Fuerst G; Poll LW; Piechaczek C; Burchardt ER; Feifel N; Stoldt V; Stockschläder M; Stoecklein N; Tustas RY; Eisenberger CF; Peiper M; Häussinger D; Hosch SB
Stem Cells; 2005 Apr; 23(4):463-70. PubMed ID: 15790766
[TBL] [Abstract][Full Text] [Related]
5. In situ split plus portal vein ligation (ISLT) - a salvage procedure following inefficient portal vein embolization to gain adequate future liver remnant volume prior to extended liver resection.
Lehwald-Tywuschik N; Vaghiri S; Schulte Am Esch J; Alaghmand S; Klosterkemper Y; Schimmöller L; Lachenmayer A; Ashmawy H; Krieg A; Topp SA; Rehders A; Knoefel WT
BMC Surg; 2020 Apr; 20(1):63. PubMed ID: 32252737
[TBL] [Abstract][Full Text] [Related]
6. Portal vein embolization prior to major liver resection.
Kuo SC; Azimi-Tabrizi A; Briggs G; Maher R; Harrington T; Samra JS; Drummond M; Hugh TJ
ANZ J Surg; 2014 May; 84(5):341-5. PubMed ID: 23231008
[TBL] [Abstract][Full Text] [Related]
7. Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.
Deshayes E; Piron L; Bouvier A; Lapuyade B; Lermite E; Vervueren L; Laurent C; Pinaquy JB; Chevallier P; Dohan A; Rode A; Sengel C; Guillot C; Quenet F; Guiu B
BMC Cancer; 2020 Jun; 20(1):574. PubMed ID: 32560632
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.
Fichtl J; Treska V; Lysak D; Mirka H; Duras P; Karlikova M; Skalicky T; Vodička J; Topolcan O
Anticancer Res; 2016 Apr; 36(4):1901-7. PubMed ID: 27069178
[TBL] [Abstract][Full Text] [Related]
9. Autologous CD133+ cells augment the effect of portal embolization.
Canepa MC; Quaretti P; Perotti C; Vercelli A; Rademacher J; Peloso A; Barbieri L; Franchi E; Briani L; Gaspari A; Brugnatelli S; Pedrazzoli P; Dionigi P; Maestri M
Minerva Chir; 2013 Apr; 68(2):163-8. PubMed ID: 23612229
[TBL] [Abstract][Full Text] [Related]
10. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.
Hwang S; Lee SG; Ko GY; Kim BS; Sung KB; Kim MH; Lee SK; Hong HN
Ann Surg; 2009 Apr; 249(4):608-16. PubMed ID: 19300228
[TBL] [Abstract][Full Text] [Related]
11. Portal vein embolisation with application of haematopoietic stem cells in patients with primarily or non-resectable colorectal liver metastases.
Treska V; Liska V; Fichtl J; Lysak D; Mirka H; Bruha J; Duras P; Treskova I; Nahlik J; Simanek V; Topolcan O
Anticancer Res; 2014 Dec; 34(12):7279-85. PubMed ID: 25503161
[TBL] [Abstract][Full Text] [Related]
12. [Portal vein embolization--increased chance for liver resecability for malignancies].
Liska V; Treska V; Mírka H; Novák M; Slauf F; Skalický T; Sutnar A; Kormunda S
Rozhl Chir; 2007 Feb; 86(2):97-101; discussion 102. PubMed ID: 17436675
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival and disease recurrence following portal vein embolisation prior to major hepatectomy for colorectal metastases.
Pamecha V; Glantzounis G; Davies N; Fusai G; Sharma D; Davidson B
Ann Surg Oncol; 2009 May; 16(5):1202-7. PubMed ID: 19130138
[TBL] [Abstract][Full Text] [Related]
14. Portal Vein Embolization Followed by Liver Resection versus Liver Resection Alone: a Comparison of Liver Regeneration Dynamics.
Meyer IA; Vandoni RE; Alerci M; Raptis DA; Gertsch P
Hepatogastroenterology; 2015 Jun; 62(140):987-91. PubMed ID: 26902042
[TBL] [Abstract][Full Text] [Related]
15. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.
Capussotti L; Muratore A; Baracchi F; Lelong B; Ferrero A; Regge D; Delpero JR
Arch Surg; 2008 Oct; 143(10):978-82; discussion 982. PubMed ID: 18936377
[TBL] [Abstract][Full Text] [Related]
16. Portal Vein Embolization with Contralateral Application of Stem Cells Facilitates Increase of Future Liver Remnant Volume in Patients with Liver Metastases.
Ludvík J; Duras P; Třeška V; Matoušková T; Brůha J; Fichtl J; Lysák D; Ferda J; Baxa J
Cardiovasc Intervent Radiol; 2017 May; 40(5):690-696. PubMed ID: 28091729
[TBL] [Abstract][Full Text] [Related]
17. Portal Vein Embolization (PVE)
Treska V; Fichtl J; Ludvik J; Bruha J; Liska V; Treskova I; Kucera R; Topolcan O; Lysak D; Skalicky T; Ferda J
Anticancer Res; 2018 Sep; 38(9):5531-5537. PubMed ID: 30194213
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.
Elias D; Santoro R; Ouellet JF; Osmak L; de Baere T; Roche A
Hepatogastroenterology; 2004; 51(60):1788-91. PubMed ID: 15532827
[TBL] [Abstract][Full Text] [Related]
19. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.
Tschuor Ch; Croome KP; Sergeant G; Cano V; Schadde E; Ardiles V; Slankamenac K; Clariá RS; de Santibaňes E; Hernandez-Alejandro R; Clavien PA
Eur J Surg Oncol; 2013 Nov; 39(11):1230-5. PubMed ID: 23994139
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection.
Wakabayashi H; Yachida S; Maeba T; Maeta H
Hepatogastroenterology; 2002; 49(46):1048-52. PubMed ID: 12143199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
